ORIGINAL RESEARCH article

Front. Neuroinform., 24 May 2018

Volume 12 - 2018 | https://doi.org/10.3389/fninf.2018.00027

New Protocol for Quantitative Analysis of Brain Cortex Electroencephalographic Activity in Patients With Psychiatric Disorders

  • 1. Faculty of Mathematics, Physics and Computer Science, Institute of Computer Science–Department of Neuroinformatics, Maria Curie-Sklodowska University in Lublin, Lublin, Poland

  • 2. Neurophysiological Independent Unit of the Department of Psychiatry, Medical University of Lublin, Lublin, Poland

Article metrics

View details

34

Citations

5,3k

Views

1,4k

Downloads

Abstract

The interview is still the main and most important tool in psychiatrist's work. The neuroimaging methods such as CT or MRI are widely used in other fields of medicine, for instance neurology. However, psychiatry lacks effective quantitative methods to support of diagnosis. A novel neuroinformatic approach to help clinical patients by means of electroencephalographic technology in order to build foundations for finding neurophysiological biomarkers of psychiatric disorders is proposed. A cohort of 30 right-handed patients (21 males, 9 females) with psychiatric disorders (mainly with panic and anxiety disorder, Asperger syndrome as well as with phobic anxiety disorders, schizophrenia, bipolar affective disorder, obsessive-compulsive disorder, nonorganic hypersomnia, and moderate depressive episode) were examined using the dense array EEG amplifier in the P300 experiment. The results were compared with the control group of 30 healthy, right-handed male volunteers. The quantitative analysis of cortical activity was conducted using the sLORETA source localization algorithm. The most active Brodmann Areas were pointed out and a new quantitative observable of electrical charge flowing through the selected Brodmann Area is proposed. The precise methodology and research protocol for collecting EEG data as well as the roadmap of future investigations in this area are presented. The essential result of this study is the idea proven by the initial results of our experiments that it is possible to determine quantitatively biomarkers of particular psychiatric disorders in order to support the process of diagnosis and hopefully choose most appropriate medical treatment later.

1. Introduction

In the last two decades renaissance of electroencephalographic techniques was observed. Known for more than one hundred years the electroencephalography (EEG) was mainly used for the diagnosis of epilepsy. Recently there has been a rapid expansion of Brain-Computer Interfaces (BCI) in which the acquisition of electrical activity of selected areas of brain cortex plays the main role (Mikolajewska and Mikolajewski, 2012, 2013, 2014) as in all the works related to Steady State Visually Evoked Potentials (SSVEP) (Kotyra and Wojcik, 2017b) or neurofeedback largely related to it (Lubar et al., 1995; Kotyra and Wojcik, 2017a) or other cognitive research (Martínez-Rodrigo et al., 2017). New neuroimaging methods such as Low-Resolution Brain Electromagnetic Tomography (LORETA) (Pascual-Marqui et al., 1994) and its standardized version (sLORETA) (Pascual-Marqui, 2002) were developed. Owing to these new quantitative and visualization methods brain activity can be investigated in new aspects. In addition, using EEG is cheaper than using Magnetic Resonance Imaging (MRI), noninvasive and has much better temporal resolution compared to the in functional MRI (Tohka and Ruotsalainen, 2012).

The clinical interview is still the main diagnostic method used in current psychiatry. However, the EEG seems to be a useful tool to support the psychiatrist (Sand et al., 2013). A wide range of psychiatric disorders is not possible to be diagnosed based on MRI, while some EEG methods seem to be appropriate for the diagnosis support in psychiatry (Kamarajan and Porjesz, 2015).

Our investigations were aimed at finding whether there are some biomarkers in the electrical cortical activity of the brain and whether they are characteristic of particular disorders as in some attempts made by John in late eighties (John et al., 1988). Some neurophysiological markers were found for example in research on burn-out syndrome (Golonka et al., 2017) which is also in the area of our interests (Chow et al., 2018).

Event-Related Potentials (ERP) were extensively investigated by experimental psychologists (Campanella, 2013), among others, to understand better engagement and working memory mechanisms (Pope et al., 1995; Chaouachi et al., 2010; Jones and Macken, 2015).

Cognitive functions in the patients with psychiatric disorders are not as effective as among healthy representatives of the populations (Niedermeyer and da Silva, 2005; Trivedi, 2006). Decision-take processes and reaction time seem to be crucial in these areas and our own studies as well as literature reviews (Brown et al., 1982) show that there were many attempts to carry out research on patients with disorders using P300. Some P300 analyses of patients with schizophrenia are presented in Jeon and Polich (2003) while panic disorders were investigated, e.g., in Clark et al. (1996). Phobias, among others spider phobia manifesting in P300 waves are presented in Leutgeb et al. (2009), Scharmüller et al. (2011), and Kolassa et al. (2006). The amplitude of P300 was investigated by Gangadhar in the early nineties (Gangadhar et al., 1993) for melancholic non-bipolar depression and by Himani in major depression (Himani et al., 1999). The auditory version of P300 is quite often used for the investigations of patients with Autism Spectrum Disorder (Souza et al., 1995; Devoto et al., 2003; Schulze et al., 2008; Cui et al., 2017) whereas the P300 for sleep disorders in Devoto et al. (2003). That is why we decided to use P300 for the research carried out on our cohort including the patients with all above mentioned diagnoses.

The paper presents the quantitative analysis of brain cortex electrical activity using the sLORETA algorithm for the signal collected by the dense array EEG amplifier supported by a photogrammetric station from the patients with selected psychiatric disorders compared to the control group. The research protocol using ERP in patients is also presented. A new observable that will allow to assess how much electrical charge flew through the particular Brodmann Area (BA) is introduced.

2. Materials and methods

It is assured that many EEG biomarkers can manifest themselves during the decision-making process and that is why the Event-Related Potentials (ERP) experiments ought to be suitable for their detection. There was chosen the well-known P300 experiment (Chapman and Bragdon, 1964; Sutton et al., 1965) to investigate a group of patients with a wide range of psychiatric disorders classified in ICD-10 as: F20 (schizophrenia), F31 (bipolar affective disorder), F32.1 (moderate depressive episode), F40 (phobic anxiety disorders), F41 (other anxiety disorders, panic disorder), F42 (obsessive-compulsive disorder), F51.1 (nonorganic hypersomnia), F84.5 (Asperger syndrome).

There are several procedures to evoke the P300 wave. In general, the idea of P300 experiment is strongly associated with the methodology of Event-Related Potentials (Nidal and Malik, 2014). The subject is most often asked to press a button whenever he or she can see the awaited symbol (called “Target”) on the monitor screen. There are two kinds of symbols appearing on the screen. Thus besides Targets (TGTs), there are the symbols called “Standard” (STDs). In P300 there are always much fewer TGTs than STDs and their proportion in the whole set of symbols is to be set. The ERP wave has statistical characteristics so many trials must be made to calculate the wave for each subject precisely. STDs and TGTs are usually shown in the series in the number from several dozens to several hundred symbols shown in each series.

Both kinds of symbols were shown on black screens for 500 ms. To sum up, the activity during the cortical response of the subject to 300 symbols (3 series × 100), with the total 60 TGTs and 240 STDs was collected.

During the experiment patients were asked to press a button on the response pad whenever they saw the “cross” sign on the monitor screen. There were four series (first of them was a testing series) of 100 stimuli in each, 20% of stimuli were white crosses as TGTs and 80% were white circles as STDs. In all subjects, the P300 wave appeared, however, it was the most important for us to check which region of the brain was active in the case of particular subject compared to the control group with the distinction of TGT and STD responses.

In the Department of Neuroinformatics there was 256-channel dense array EEG amplifier provided by EGI1 with the Net Station v. 4.5.4 signal acquisition software. Laboratory (see Figure 1) is also supported by the Geodesic Photogrammetry System (GPS) with the Net Local 1.00.00 and GeoSource 2.0 software that are able to conduct the source localization procedure and sLORETA visualization. Saccadic eye movements and eye blinks were eliminated by the SmartEye 5.9.7 controlling the eye-tracker system that is an integral part of EGI lab. Event-Related Potentials (ERP) experiments were prepared in the PST e-Prime 2.0.8.90 tool2.

Figure 1

After the EEG signal was collected the pre-processing analysis was made by removing artifacts (mainly eye-blinking and saccades) and later there was applied sLORETA algorithm to it (Figure 2). Due to the appliance of GPS it was possible to indicate with a very good precision to the subject's cortex BAs that were the most active during his or her responses to the STD and TGT stimuli. The time interval in which the BA activity was calculated was set to 5 ms.

Figure 2

The sLORETA used in our Laboratory was the most standard version of the algorithm described in detail in the Brain Source Localization Using EEG Signals chapter of Nidal and Malik (2014). The sLORETA method assumes the standardization of the current density. That means that not only the variance of the noise in the EEG measured signal is taken into account but also that the biological variance in the actual signal is considered (Goldenholz et al., 2009; Nidal and Malik, 2014). These biological activity changes are taken as independently and uniformly distributed across the brain. This results in a linear imaging localization technique having an exact zero-localization error (Goldenholz et al., 2009; Nidal and Malik, 2014). The perfect and detailed comparison of different variations of LORETA is presented in Nidal and Malik (2014).

In addition, the GeoSource software makes it possible to estimate amperage of the most active areas (Figure 3) varying in time. The reason for which a new observable was considered originated from the fact that particular BA could last at its maximum value for a longer or shorter period of time and it could appear more than once during each epoch. The signal was divided into epochs, as usual in P300 experiments, then averaged giving amperage in function of time.

Figure 3

The electric current flowing through each BA is expressed by:

where q(BA, τ, t, |ψ〉) is the electric charge which accumulates in the BA for estimated period time after the stimulation τ and surely depends on some set of psychophysiological parameters represented by the vector |Ψ〉.

Our new observable ι (Iota) is defined as the electric charge that flew through the given BA given by the integral:

in the time range limited by t1 = 280 ms and t2 = 600 ms after stimulation that took place in time τ. That range is reasonably chosen in P300 investigations as the most appropriate time to observe P300 wave.

Based on the electrical current measured by the amplifier, particular BAs precisely indicated by the photogrammetry station and having sharply estimated time intervals owing to the perfect EEG time resolution, one of many numerical methods for integration can be applied to calculate ι with good precision. This variable can be calculated for each BA, for everyone, no matter if the subject is healthy or suffers from any disorder. However, the systematic clinical validation must be conducted and finding correlations with the clinical symptoms as well as the comparison between healthy peers should be of top priority in future research. The aim of this paper was not to solve the above mentioned medical problems but to show the method that may be useful for working out new diagnosis support tools.

The Scheme of the methodology and research protocol are presented in Figure 4.

Figure 4

3. Results

The cohort of untreated 30 patients, 21 right-handed males, and 9 right-handed females (avg. age 28.1, s.d. 12.4) was investigated in the P300 experiment. All patients participated in the experiment before taking the first dose of suggested medications.

The patients were with a wide range of diagnosed psychiatric disorders classified in ICD-10 as: 1 × F20 (schizophrenia), 3 × F31 (bipolar affective disorder), 4 × F32.1 (moderate depressive episode), 2 × F40 (phobic anxiety disorders), 12 × F41 (other anxiety disorders, panic disorder), 2 × F42 (obsessive-compulsive disorder—among patients with F84.5), 2 × F51.1 (nonorganic hypersomnia), 6 × F84.5 (asperger syndrome).

The results are compared with the participants from the control group of 30 healthy volunteers, males (avg. age 22.4, s.d. 1.7)3.

The members of the control group were right-handed (like all the subjects) males and claimed that they had neither psychiatric no neurological problems. They were not treated before. They confirmed not taking medicines in a regular way. They were not drug addicted and did not use alcohol for at least two days prior the investigations. The control group was selected from the students of Computer Science and Cognitive Science at Maria Curie-Sklodowska University in Lublin, Poland. All of them estimated their general medical condition as good or very good. Only the subjects with the above characteristics could become members of the control group. Females, left-handed and all with neurological traits were excluded in this stage of the project. We are aware of the fact that gender plays a significant role in EEG experiments. As a baseline, there were chosen only males for the control group and in future, separate research for particular genders is going to be carried out.

The procedure of estimating the most active BAs was as follows: after the signal acquisition, the photo of the subject was taken using 11 cameras in the GPS. Then there was calculated the activity of particular BAs (in nanoamperes) varying in time and this varying activity together with its corresponding BAa was saved in the appropriate list using the GeoSource software. Then the scripts chose the activity that was the greatest in a given interval of time. Not only the maximum value of the electrical current of given BA in a given interval was considered but also the time in the range of this interval in which this activity was maintained. In other words, the maximum activity was equivalent to the electric charge that flew through the given area.

The Results for the group of patients are presented in Table 1 (most active BA) and Table 2 (ι calculated for the most active BA).

Table 1

Patient No.Diag.STD most active BATGT most active BA
1F20L23S1
2F31R46R46
3F31S1S1
4F31R9R9
5F32.1S1R9
6F32.1LHipp, R41LHipp, R41
7F32.1L36, R36L36, R36
8F32.1R9R36
9F40R41LAmyg
10F40R46, R41R46, R42
11F41S1R44, L43
12F41S1R9
13F41S1S1
14F41R28S1
15F41S1S1
16F41R9R9
17F41S1S1
18F41L27, L33L27
19F41S1L45
20F41R4LAmyg
21F41S1R45
22F41S1S1
23F51.1L36, R9L27
24F51.1S1S1
25F84.5L45LHipp
26F84.5Amyg, R44R9
27F84.5, F42L45L45
28F84.5, F42R9R9
29F84.5L45, R9R9
30F84.5R39, LHippL37, L45

Most active BA in particular patients during the P300 experiment as obtained from the sLORETA quantitative analysis.

“Amyg” stands for Amygdala, “Hipp” for left Hippocampus areas. S1 for the areas of Primary Somatosensory Cortex. L-R for Left - Right hemisphere, respectively.

Table 2

No.Diag.ι (STD)[μC]ι (TGT) [μC]
1F2033.5S1
2F312.1120.1
3F31S1S1
4F3176.475.3
5F32.1S175.5
6F32.15.20, 2.352.99, 28.5
7F32.117.3, 21.024.4, 14.4
8F32.15.68S1
9F401.072.09
10F4010.6, 5.6638.9, 16.1
11F41S1139, 629
12F41S12.53
13F41S1S1
14F413.44S1
15F41S1S1
16F413.2925.3
17F41S1S1
18F4113.4, 13.343.7
19F41S13.72
20F410.8551.85
21F41S120.5
22F41S1S1
23F51.118.2, 21.463.8
24F51.10S1S1
25F84.53.982.17
26F84.51.25, 1.756.21
27F84.5. F4238.7124
28F84.5. F421.74.63
29F84.513.3, 1.9230.3
30F84.523.8, 5.8878.5, 6.48

The ι for the most active BA in particular patients during the P300 experiment for the STD and TGT responses obtained from the sLORETA quantitative analysis.

S1 indicated the activity in Primary Somatosensory Cortex and was neglected in the calculations of ι. Compare with Table 1.

The Results for the control group are presented in Table 3 (most active BA) and Table 4 (ι calculated for most active BA).

Table 3

No.STD most active BATGT most active BA
1S1L33, L9
2S1S1
3S1L46
4S1R9
5L18S1
6R9S1
7R9S1
8R33R33, R45
9R23R45
10RHippLHipp, R9
11S1R9
12S1R9
13R9R41, L33
14R7S1
15R9S1
16R33R33
17S1R9
18L44, L33R44
19S1S1
20S1S1
21S1S1
22S1S1
23R9R9, L46
24S1L45
25LAmyg, R33S1
26R9L46
27R9R9
28R9R9
29S1LAmyg
30S1S1

Most active BA in the particular subjects of the control group during the P300 experiment as obtained from the sLORETA quantitative analysis.

“Amyg” indicates Amygdala, “Hipp” the Hippocampus areas. S1 for the areas of Primary Somatosensory Cortex. L-R for the Left-Right hemisphere, respectively.

Table 4

No.ι (STD) [μC]ι (TGT) [μC]
1S14.46.4.14
2S1S1
3S18.31
4S13.12
52.5S1
62.5S1
73.75S1
81129.2;8.90
99.4711
104.334.61;52.8
11S155.4
12S170.5
1319.920.9; 2.54
141.64S1
151.04S1
1618.755.6
17S111.9
188.65; 24.924.9
19S1S1
20S1S1
21S1S1
22S1S1
2328.58.49;1.78
24S119.2
257.66;1.12S1
266.951.71
275.293.26
2854.93.2
29S11.91
30S1S1

The ι for the most active BA in particular subjects of the control group during the P300 experiment for the STD and TGT responses obtained from the sLORETA quantitative analysis.

S1 indicates the activity in Primary Somatosensory Cortex and was neglected in the calculations of ι. Compare with Table 3.

Determining biomarkers for different psychiatric patients that have very different symptoms and clinical characteristics seem a challenging task. The aim of this paper was not, however, to hypothesize dysfunctions of some parts of the brain in particular disorders but to show a new way in which this can be done. In the group of 30 there were representatives of 8 different diagnoses. Under ideal conditions it would be proper to have c.a. 30 patients of each gender and handedness as well as in three ranges of age. That would make us to record systematically the electrical activity of 1,440 patients only for these 8 disorders. However, there are much more described in ICD-10.

Most active BAs were manually counted for particular disorders reported in Table 1. It is still too far to define any psychiatric hypotheses, however, in the next section, the most active BAs together with their known function in the brain are presented.

4. Discussion

In all participants both from the patients and control groups high activity of Primary Somatosensory Cortex was observed. BA1, BA2, and BA3 are all together marked as S1 in Tables 1, 3. It is not surprising as all subjects used a response pad to press the button each time they saw TGT. Nevertheless, it can be interesting that S1 was active even in lots of STD trials when fingers were on the response pad but they were not clicking.

There is no clear difference between the subjects from the patients and the control group that would allow us to show biomarkers characteristic of particular disorders.

However, in the group of patients suffering from F41 (12 patients), both left and right BA45 and right BA44 were hyperactive in a few TGT cases. Anatomically BA45 and BA44 are in the Broca's areas and are supposed to play a role in semantic tasks (Buckner, 1996; Gabrieli et al., 1998). This activity was not expected in the standard P300 experiment.

Among the patients suffering from F32.1, both left and right BA36 (perirhinal cortex in the rhinal sulcus) seem to be more active than anywhere else. According to Murray (Murray et al., 2007), this region is involved in perception and memory.

For the patients with the Asperger syndrome (F84.5), a larger activity can be found in the left BA45 as well as in Hippocampus.

This is the initial stage of our project. The research protocol is proposed and it is hypothesized that there are characteristic biomarkers in the EEG signal for selected disorders. The is also introduced the measure called ι that may be helpful in some cases to enrich typical source localization based quantitative analysis.

Such an approach can be treated as a foundation of new methods for support of diagnosis in psychiatry. Finding neurophysiological biomarkers of psychiatric disorders can be easier if the results from Tables 2, 4 are compared with iotas from Tables 2, 4. However, to achieve any clinical results, much more patients that were not treated before are needed. With so many disorders listed in ICD-10, this task seems to be extremely hard but not impossible. This will require the design of appropriate neuroinformatic infrastructure, e.g., like Bigdely-Shamlo et al. (2016).

The method shown herein will require definitely some improvements and support. Probably the analysis using the artificial neural networks that have lots of applications in medical problems (Szaleniec et al., 2008, 2013) could be also helpful for predictions and qualification of psychiatric disorders (Cavanagh et al., 2017). On the other hand, our hypotheses could be supported by using modeling of neural activity in which we are experienced (Wojcik et al., 2007; Wojcik and Kaminski, 2008; Wojcik and Garcia-Lazaro, 2010). Good modeling can shed some light on the ERP design (Ważny and Wojcik, 2014; Wojcik and Ważny, 2015) especially when electrophysiological parameters of neural cells are taken into account (Wojcik and Kaminski, 2007; Wojcik, 2012). It is certain, that joining skills from a wide spectrum of neuroscience will at last lead to new discoveries and better understanding of the human brain, behavior, and mental dysfunctions. Moreover, better understanding will allow designing new tools to help human beings.

Statements

Ethics statement

This study was carried out in accordance with the recommendations of Guidelines for Good Clinical Practice (GCP). The protocol was approved by the Medical University of Lublin Bioethical Commission. All subjects gave written informed consent in accordance with the GCP. Permission No. KE-0254/140/2015 given by Medical University of Lublin Bioethical Commission on May 28th, 2015.

Author contributions

GW: project idea and coordination, experiment design, subjects' recruitment, results' interpretation. JM: project idea, experiment design, subjects' recruitment, psychiatric diagnosis, results' interpretation. AK: work in laboratory, cleaning signal, computations, statistical analysis. PS and LK: statistical analysis, writing scripts, work in laboratory, cleaning signal. NP: work in laboratory. AG-B: work in laboratory.

Acknowledgments

Special thanks are given to Slawomir Kotyra, MSc. from the Institute of Computer Science, Maria Curie-Sklodowska University in Lublin for solving the problem of electromagnetic noise in our laboratory.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Footnotes

1.^Electrical Geodesic Systems, Inc., 500 East 4th Ave. Suite 200, Eugene, OR 97401, USA.

2.^Psychology Software Tools, Inc.PST, Sharpsburg Business Park, 311 23rd Street Ext., Suite 200, Sharpsburg, PA 15215-2821 USA.

3.^In fact, there were investigated about 30% more subjects both patients and control group, but all those for whom the signal was too noisy or incomplete were eliminated.

References

  • 1

    Bigdely-ShamloN.MakeigS.RobbinsK. A. (2016). Preparing laboratory and real-world eeg data for large-scale analysis: a containerized approach. Front. Neuroinform.10:7. 10.3389/fninf.2016.00007

  • 2

    BrownW.MarshJ.LaRueA. (1982). Event-related potentials in psychiatry: differentiating depression and dementia in the elderly. Bull. Los Angeles Neurol. Soc.47, 91107.

  • 3

    BucknerR. L. (1996). Beyond HERA: contributions of specific prefrontal brain areas to long-term memory retrieval. Psychon. Bull. Rev.3, 149158.

  • 4

    CampanellaS. (2013). Why it is time to develop the use of cognitive event-related potentials in the treatment of psychiatric diseases. Neuropsychiatr. Dis. Treat.9, 18351845. 10.2147/NDT.S53687

  • 5

    CavanaghJ. F.NapolitanoA.WuC.MueenA. (2017). The patient repository for EEG data+ computational tools (PRED+ CT). Front. Neuroinform.11:67. 10.3389/fninf.2017.00067

  • 6

    ChaouachiM.ChalfounP.JraidiI.FrassonC. (2010). Affect and mental engagement: towards adaptability for intelligent systems, in Proceedings of the 23rd International FLAIRS Conference (Citeseer).

  • 7

    ChapmanR. M.BragdonH. R. (1964). Evoked responses to numerical and non-numerical visual stimuli while problem solving. Nature203, 11551157.

  • 8

    ChowY.MasiakJ.MikołajewskaE.MikołajewskiD.WójcikG. M.WallaceB.et al. (2018). Limbic brain structures and burnout - a systematic review. Adv. Med. Sci.63, 192198. 10.1016/j.advms.2017.11.004

  • 9

    ClarkC. R.McFarlaneA. C.WeberD. L.BattersbyM. (1996). Enlarged frontal p300 to stimulus change in panic disorder. Biol. Psychiatry39, 845856.

  • 10

    CuiT.WangP. P.LiuS.ZhangX. (2017). P300 amplitude and latency in autism spectrum disorder: a meta-analysis. Eur. Child Adolesc. Psychiatry26, 177190. 10.1007/s00787-016-0880-z

  • 11

    DevotoA.ViolaniC.LucidiF.LombardoC. (2003). P300 amplitude in subjects with primary insomnia is modulated by their sleep quality. J. Psychosom. Res.54, 310. 10.1016/S0022-3999(02)00579-2

  • 12

    GabrieliJ. D.PoldrackR. A.DesmondJ. E. (1998). The role of left prefrontal cortex in language and memory. Proc. Natl. Acad. Sci. U.S.A.95, 906913.

  • 13

    GangadharB.AncyJ.JanakiranaiahN.UmapathyC. (1993). P300 amplitude in non-bipolar, melancholic depression. J. Affect. Disord.28, 5760.

  • 14

    GoldenholzD. M.AhlforsS. P.HämäläinenM. S.SharonD.IshitobiM.VainaL. M.et al. (2009). Mapping the signal-to-noise-ratios of cortical sources in magnetoencephalography and electroencephalography. Hum. Brain Mapp.30, 10771086. 10.1002/hbm.20571

  • 15

    GolonkaK.Mojsa-KajaJ.PopielK.MarekT.GawlowskaM. (2017). Neurophysiological markers of emotion processing in burnout syndrome. Front. Psychol.8:2155. 10.3389/fpsyg.2017.02155

  • 16

    HimaniA.TandonO.BhatiaM. (1999). A study of p300-event related evoked potential in the pateints of major depression. Indian J. Physiol. Pharmacol.43, 367372.

  • 17

    JeonY.-W.PolichJ. (2003). Meta-analysis of p300 and schizophrenia: patients, paradigms, and practical implications. Psychophysiology40, 684701. 10.1111/1469-8986.00070

  • 18

    JohnE. R.PrichepL.FridmanJ.EastonP. (1988). Neurometrics: computer-assisted differential diagnosis of brain dysfunctions. Science239, 162169.

  • 19

    JonesG.MackenB. (2015). Questioning short-term memory and its measurement: why digit span measures long-term associative learning. Cognition144, 113. 10.1016/j.cognition.2015.07.009

  • 20

    KamarajanC.PorjeszB. (2015). Advances in electrophysiological research. Alcohol Res.37, 5387.

  • 21

    KolassaI.-T.MusialF.KolassaS.MiltnerW. H. (2006). Event-related potentials when identifying or color-naming threatening schematic stimuli in spider phobic and non-phobic individuals. BMC Psychiatry6:38. 10.1186/1471-244X-6-38

  • 22

    KotyraS.WojcikG. M. (2017a). The station for neurofeedback phenomenon research, in Polish Conference on Biocybernetics and Biomedical Engineering (Cham: Springer), 3243.

  • 23

    KotyraS.WojcikG. M. (2017b). Steady state visually evoked potentials and their analysis with graphical and acoustic transformation, in Polish Conference on Biocybernetics and Biomedical Engineering (Cham: Springer), 2231.

  • 24

    LeutgebV.SchäferA.SchienleA. (2009). An event-related potential study on exposure therapy for patients suffering from spider phobia. Biol. Psychol.82, 293300. 10.1016/j.biopsycho.2009.09.003

  • 25

    LubarJ. F.SwartwoodM. O.SwartwoodJ. N.O'DonnellP. H. (1995). Evaluation of the effectiveness of EEG neurofeedback training for ADHD in a clinical setting as measured by changes in T.O.V.A. scores, behavioral ratings, and WISC-R performance. Biofeedback Self Regul.20, 8399.

  • 26

    Martínez-RodrigoA.Fernández-SotosA.LatorreJ. M.Moncho-BoganiJ.Fernández-CaballeroA. (2017). Neural correlates of phrase rhythm: an EEG study of bipartite vs. rondo sonata form. Front. Neuroinform.11:29. 10.3389/fninf.2017.00029

  • 27

    MikolajewskaE.MikolajewskiD. (2012). Neuroprostheses for increasing disabled patients' mobility and control. Adv. Clin. Exp. Med.21, 263272.

  • 28

    MikolajewskaE.MikolajewskiD. (2013). Ethical considerations in the use of brain-computer interfaces. Centr. Eur. J. Med.8, 720724. 10.2478/s11536-013-0210-5

  • 29

    MikolajewskaE.MikolajewskiD. (2014). The prospects of brain–computer interface applications in children. Open Med.9, 7479. 10.2478/s11536-013-0249-3

  • 30

    MurrayE. A.BusseyT. J.SaksidaL. M. (2007). Visual perception and memory: a new view of medial temporal lobe function in primates and rodents. Annu. Rev. Neurosci.30, 99122. 10.1146/annurev.neuro.29.051605.113046

  • 31

    NidalK.MalikA. S. (2014). EEG/ERP Analysis: Methods and Applications. Boca Raton, FL; London, UK; New York, NY: Crc Press

  • 32

    NiedermeyerE.da SilvaF. L. (2005). Electroencephalography: Basic Principles, Clinical Applications, and Related Fields. Philadelphia, PA; Baltimore, MD; New York, NY; London UK; Buenos Aires; Hong-Kong; Sydney NSW; Tokyo: Lippincott Williams & Wilkins.

  • 33

    Pascual-MarquiR. D. (2002). Standardized low-resolution brain electromagnetic tomography (sloreta): technical details. Methods Find. Exp. Clin. Pharmacol.24(Suppl. D), 512.

  • 34

    Pascual-MarquiR. D.MichelC. M.LehmannD. (1994). Low resolution electromagnetic tomography: a new method for localizing electrical activity in the brain. Int. J. Psychophysiol.18, 4965.

  • 35

    PopeA. T.BogartE. H.BartolomeD. S. (1995). Biocybernetic system evaluates indices of operator engagement in automated task. Biol. Psychol.40, 187195.

  • 36

    SandT.BjørkM.VaalerA. (2013). Is EEG a useful test in adult psychiatry?Tidsskr. Nor. Laegeforen.133, 12001204. 10.4045/tidsskr.12.1253

  • 37

    ScharmüllerW.LeutgebV.SchäferA.KöchelA.SchienleA. (2011). Source localization of late electrocortical positivity during symptom provocation in spider phobia: an sLORETA study. Brain Res.1397, 1018. 10.1016/j.brainres.2011.04.018

  • 38

    SchulzeK. K.HallM.-H.McDonaldC.MarshallN.WalsheM.MurrayR. M.et al. (2008). Auditory p300 in patients with bipolar disorder and their unaffected relatives. Bipolar Disord.10, 377386. 10.1111/j.1399-5618.2007.00527.x

  • 39

    SouzaV. B.MuirW. J.WalkerM. T.GlabusM. F.RoxboroughH. M.SharpC. W.et al. (1995). Auditory p300 event-related potentials and neuropsychological performance in schizophrenia and bipolar affective disorder. Biol. Psychiatry37, 300310.

  • 40

    SuttonS.BrarenM.ZubinJ.JohnE. (1965). Evoked-potential correlates of stimulus uncertainty. Science150, 11871188.

  • 41

    SzaleniecJ.WiatrM.SzaleniecM.SkłAdzieńJ.TomikJ.OleśK.et al. (2013). Artificial neural network modelling of the results of tympanoplasty in chronic suppurative otitis media patients. Comput. Biol. Med.43, 1622. 10.1016/j.compbiomed.2012.10.003

  • 42

    SzaleniecM.TadeusiewiczR.WitkoM. (2008). How to select an optimal neural model of chemical reactivity?Neurocomputing72, 241256. 10.1016/j.neucom.2008.01.003

  • 43

    TohkaJ.RuotsalainenU. (2012). Imaging brain change across different time scales. Front. Neuroinform.6:29. 10.3389/fninf.2012.00029

  • 44

    TrivediJ. (2006). Cognitive deficits in psychiatric disorders: current status. Indian J. Psychiatry48, 1020. 10.4103/0019-5545.31613

  • 45

    WażnyM.WojcikG. M. (2014). Shifting spatial attention-numerical model of posner experiment. Neurocomputing135, 139144. 10.1016/j.neucom.2013.12.043

  • 46

    WojcikG. M. (2012). Electrical parameters influence on the dynamics of the hodgkin–huxley liquid state machine. Neurocomputing79, 6874. 10.1016/j.neucom.2011.10.007

  • 47

    WojcikG. M.Garcia-LazaroJ. A. (2010). Analysis of the neural hypercolumn in parallel pcsim simulations. Proc. Comput. Sci.1, 845854. 10.1016/j.procs.2010.04.092

  • 48

    WojcikG. M.KaminskiW. A. (2007). Liquid state machine and its separation ability as function of electrical parameters of cell. Neurocomputing70, 25932597. 10.1016/j.neucom.2006.12.015

  • 49

    WojcikG. M.KaminskiW. A. (2008). Self-organised criticality as a function of connections number in the model of the rat somatosensory cortex, in International Conference on Computational Science (Berlin; Heidelberg: Springer), 620629.

  • 50

    WojcikG. M.KaminskiW. A.MatejankaP. (2007). Self-organised criticality in a model of the rat somatosensory cortex, in International Conference on Parallel Computing Technologies (Berlin; Heidelberg: Springer), 468476.

  • 51

    WojcikG. M.WażnyM. (2015). Bray-curtis metrics as measure of liquid state machine separation ability in function of connections density. Proc. Comput. Sci.51, 29482951. 10.1016/j.procs.2015.05.490

Summary

Keywords

electroencephalography, sLORETA, psychiatric disorders, quantitative analysis, biomarkers, P300

Citation

Wojcik GM, Masiak J, Kawiak A, Schneider P, Kwasniewicz L, Polak N and Gajos-Balinska A (2018) New Protocol for Quantitative Analysis of Brain Cortex Electroencephalographic Activity in Patients With Psychiatric Disorders. Front. Neuroinform. 12:27. doi: 10.3389/fninf.2018.00027

Received

27 February 2018

Accepted

02 May 2018

Published

24 May 2018

Volume

12 - 2018

Edited by

Antonio Fernández-Caballero, Universidad de Castilla-La Mancha, Spain

Reviewed by

Antonio Ivano Triggiani, University of Foggia, Italy; Ali Yadollahpour, Ahvaz Jundishapur University of Medical Sciences, Iran

Updates

Copyright

*Correspondence: Grzegorz M. Wojcik

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics